Developer docs
API playgroundTry for free, no card

Search company profiles

Epica International

Full company profile

uuid0000oyl

Namestring
Epica International
Legal namestring
Epica International, Inc.
Company typeenum
Private
Founded yearint
2018
Descriptiontext

Epica International, Inc. is a privately held U.S.-headquartered holding company that designs, develops, manufactures, and distributes advanced mobile medical imaging platforms and precision robotic systems through five wholly owned subsidiaries: Epica Human Health, Epica Animal Health, Roboticom, Imaginalis, and Peregrine Radiology. Founded in 2013 with initial financing from Facilitated Growth and headquartered in Landrum, South Carolina, with operations anchored at a 27,000-square-foot assembly and warehousing facility in Duncan, SC and manufacturing/R&D in Florence and Pisa, Italy, the company employs 51-100 people across the U.S. and Europe.

The company's product portfolio spans three verticals. In human medical imaging, the SeeFactor CT3 is an FDA 510(k)-cleared and CE-marked mobile, multi-modality point-of-care platform combining HDVI CT, fluoroscopy, and digital radiography, with a 62.5cm gantry bore and 30cm field of view. In animal health, the Vimago GT30, GT30 Pico, and Pegaso Evolution platforms serve veterinary, equine, and pre-clinical/academic research markets. In industrial robotics, the Ortis Essential/Professional/Enterprise line addresses orthotics and prosthetics milling, while SandRob and ScultoRob provide surface finishing, sanding, polishing, and 7-axis milling for aerospace, automotive, and general manufacturing. The underlying HDVI technology delivers 0.2mm spatial resolution in isotropic, non-interpolated 3D imaging.

Epica generates revenue primarily through one-time hardware sales of medical imaging platforms and robotic systems, supplemented by recurring service and support contracts delivered via its 2025 partnership with Catalyst MedTech. Distribution combines direct enterprise field sales — led by a Chief Commercial Officer and divisional presidents — with channel partnerships, notably the September 2025 Esaote North America alliance. Customer base is diversified across approximately 400 veterinary/pre-clinical imaging deployments, 170+ industrial robotic customers (including Adidas, Dallara, Weiss Automotive, Delastek, and the US VA Health Care System), and emerging human-health adopters such as Spartanburg Regional Healthcare System. The company has raised more than $50 million cumulatively across debt and equity rounds, with notable growth-capital facilities from SWK Holdings ($14M, 2018) and Avenue Capital Group ($18M, 2024), and reported FY2017 third-party-certified revenue of $24.1M.

Short descriptiontext

Epica International is a privately held U.S. holding company that designs and manufactures proprietary HDVI mobile medical imaging platforms (SeeFactor CT3, Vimago) and precision robotic systems (Ortis, SandRob, ScultoRob) for human hospitals, veterinary clinics, and industrial manufacturers across the U.S. and Europe.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersSan Clemente, United States
HQ citystring
San Clemente
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices5 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
medical imaging systems, industrial robotics, orthotics prosthetics automation, mobile CT imaging, surface finishing robots
Industry5 codes
1X-ray & Fluoroscopy Systems
CodeHLAHABAAPrimaryYes
2Teleradiology Platforms & Reading Workflow
CodeHLACALAKPrimaryNo
3Imaging Informatics & Workflow (PACS/RIS/VNA)
CodeHLAHABAIPrimaryNo
4Surgical Navigation, Robotics & Patient-Matched Instrumentation (Ortho/Spine)
CodeHLAHAEALPrimaryNo
5Universal Viewers & Enterprise Imaging Access (Zero-footprint/Diagnostic)
CodeHLACALADPrimaryNo
NAICS code3 codes
  • Navigational, Measuring, Electromedical, and Control Instruments Manufacturing3345
  • Irradiation Apparatus Manufacturing334517
  • Surgical Appliance and Supplies Manufacturing339113
SIC code3 codes
  • Surgical & Medical Instruments & Apparatus3841
  • X-Ray Apparatus & Tubes & Related Irradiation Apparatus3844
  • Orthopedic, Prosthetic & Surgical Appliances & Supplies3842
Product category
Medical Imaging Equipment
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model3 records
1Medical Imaging Systems
TypeHardware Sales
Description

Sale of advanced mobile multi-modality imaging platforms (SeeFactor CT3 for human health, Vimago GT30/Pegaso for veterinary). One-time hardware sales with potential for recurring service contracts.

pharmiweb.com
2Robotic Systems
TypeHardware Sales
Description

Sale of industrial robotic automation systems (ORTIS, SandRob, ScultoRob) for manufacturing, aerospace, automotive, and orthotics/prosthetics industries. One-time equipment sales with software integration.

epicainternational.com
3Service and Support
TypeSubscription Recurring
Description

Service and support contracts through Catalyst MedTech partnership for imaging systems. Includes maintenance, repairs, and technical support.

epicainternational.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure
Pricing details3 tiers
1ORTIS Essential - Entry-level O&P robotic system
ModelOne time/ perpetual licenseBilling cadenceMulti-year contract
Notes

Entry-level configuration for orthopedic workshops; working area 24x600x1000mm; average daily production of 10 models; aluminum box enclosure; manual tool change

epicainternational.com
2ORTIS Professional - Intermediate O&P robotic system
ModelOne time/ perpetual licenseBilling cadenceMulti-year contract
Notes

Intermediate configuration for increased production; average daily production of 10-15 models; working area 28x28x48in; standard and customized configurations available

epicainternational.com
3ORTIS Enterprise - Maximum productivity O&P robotic system
ModelOne time/ perpetual licenseBilling cadenceMulti-year contract
Notes

Maximized productivity configuration; 20+ models per day; working area 1200x1200x1800mm; automatic tool changer with 10-position toolbox; robot with 2+ meter reach

epicainternational.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 10 records shown
1SeeFactor CT3
Description

Multi-modality, mobile imaging platform utilizing HDVI technology delivering 3D map of densities with spatial resolution the same in all three dimensions; FDA 510(k) Cleared for Human Use

epicainternational.com
+9 more records
Core offering1 text field

Epica International designs, manufactures, and distributes advanced mobile medical imaging platforms and precision industrial robotic systems. Its human-health imaging flagship (SeeFactor CT3) and veterinary imaging platforms (Vimago GT30, GT30 Pico, Pegaso Evolution) leverage proprietary HDVI (High Definition Volumetric Imaging) technology combining CT, fluoroscopy, and digital radiography. Its robotic portfolio (Ortis line for O&P, SandRob for surface finishing, ScultoRob for milling/carving) serves orthopedic, aerospace, automotive, and general manufacturing customers.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • CT turnaround time in ICU reduced by more than 90%
+3 more records
Product overview1 text field

Epica International is a holding company for a portfolio of technology subsidiaries developing and delivering advanced medical imaging platforms and robotic systems. The company operates three main product lines: (1) Human Medical Imaging centered on the SeeFactor CT3 mobile multi-modality platform (HDVI CT, fluoroscopy, digital radiography); (2) Veterinary Medical Imaging featuring the Vimago GT30/Pico and Pegaso Evolution platforms; and (3) Industrial Robotics including the Ortis line (Essential, Professional, Enterprise) for orthotics/prosthetics manufacturing and SandRob/ScultoRob for surface finishing and carving applications. Supporting services include Peregrine PACS telemedicine reading. Products are manufactured in Italy (Florence and Pisa) with U.S. headquarters in Spartanburg, SC and business offices in San Clemente, CA.

Product and service2 records
1SeeFactor CT3
CategoryHuman Medical Imaging
Description

Mobile, multi-modality point-of-care imaging platform combining HDVI CT, fluoroscopy, and digital radiography. FDA 510(k) cleared and CE marked for human use. Delivers ultra-high-definition, gapless, non-interpolated 2D/3D image data for diagnostic, interventional, and intraoperative applications in hospitals, surgical centers, and ICUs.

2Vimago GT30
Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierStrategicTypeChannel Partner/ Reseller/ DistributorAnnounced on2025-09-08
Description

Partnership expands market presence and accelerates adoption of high-performance MR and CT across human and veterinary sectors. Esaote strengthens imaging portfolio with Epica's CT systems while Epica gains broader reach through Esaote's established North American sales and service network. Includes coordinated sales, joint marketing, and integrated support.

Strategic tierCoreTypeImplementation/ SI/ Consulting PartnerAnnounced on2025-05-21
Description

Service partnership expands and strengthens US service infrastructure across Imaginalis and Epica Human Health to cut downtime, improve responsiveness, and deliver high-touch support. Catalyst MedTech is nationally respected leader in imaging service and support.

Strategic tierMinorTypeOthers
Description

Economic development partnership with Spartanburg County. County supportive to business and economic development; attracted Epica as innovative company. Epica's investment aligned with diversified economic development priorities targeting bioscience and life sciences industries.

Recent move10 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Medical imaging and IT solutions company with X-ray, fluoroscopy and DR portfolio, including mobile imaging. Comparable as it sells multi-modality imaging systems into the same hospital and outpatient channels.

TypeBroad incumbent
Description

Broad incumbent in diagnostic imaging, interventional and patient monitoring. Comparable as it sells directly into the same ICU/OR hospital purchasing channels that Epica targets with its mobile CT.

TypeBroad incumbent
Description

Global medical imaging incumbent with broad CT, MR and ultrasound portfolio including mobile CT solutions. Directly comparable as the dominant scale player Epica competes against in hospital imaging procurement.

TypeBroad incumbent
Description

Major CT, MR and interventional imaging incumbent with global hospital salesforce and service network. Comparable because it competes head-to-head with Epica's SeeFactor CT3 for hospital capital budgets.

TypeBroad incumbent
Description

Imaging equipment manufacturer with a strong CT portfolio, including mobile and point-of-care CT. Comparable as a peer in multi-modality diagnostic imaging capital sales to hospitals.

TypeDirect peer
Description

Italian-based diagnostic imaging company specializing in MR, ultrasound and—since the 2025 Epica partnership—CT. Direct comparable as both a peer in the imaging modality category and a distribution partner for Epica's CT in North America.

TypeEmerging player
Description

Specialty imaging OEM focused on digital mammography, CT, and orthopedic imaging. Comparable as a smaller, focused imaging manufacturer pursuing point-of-care and specialty clinical use cases similar to Epica's strategy.

TypeBroad incumbent
Description

Medical device leader with strong orthopedic and surgical robotics franchises. Comparable as it overlaps with Epica's ORTIS O&P robotic milling products and the broader surgical robotics roadmap.

TypeEmerging player
Description

Specialty surgical imaging, navigation and robotics vendor focused on image-guided surgery and intraoperative imaging. Comparable as a peer pursuing image-guided point-of-care and intraoperative imaging workflows.

TypeDirect peer
Description

Global leader in collaborative industrial robotic arms, including surface finishing, sanding and milling applications. Comparable as a direct competitor in industrial robotic automation where Roboticom's SandRob and ScultoRob operate.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers6 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability4 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles14 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries5 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds14 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors3 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Epica International

Medical Imaging Equipmentepicainternational.com

Epica International is a privately held U.S. holding company that designs and manufactures proprietary HDVI mobile medical imaging platforms (SeeFactor CT3, Vimago) and precision robotic systems (Ortis, SandRob, ScultoRob) for human hospitals, veterinary clinics, and industrial manufacturers across the U.S. and Europe.

What Epica International does

Epica International, Inc. is a privately held U.S.-headquartered holding company that designs, develops, manufactures, and distributes advanced mobile medical imaging platforms and precision robotic systems through five wholly owned subsidiaries: Epica Human Health, Epica Animal Health, Roboticom, Imaginalis, and Peregrine Radiology. Founded in 2013 with initial financing from Facilitated Growth and headquartered in Landrum, South Carolina, with operations anchored at a 27,000-square-foot assembly and warehousing facility in Duncan, SC and manufacturing/R&D in Florence and Pisa, Italy, the company employs 51-100 people across the U.S. and Europe.

The company's product portfolio spans three verticals. In human medical imaging, the SeeFactor CT3 is an FDA 510(k)-cleared and CE-marked mobile, multi-modality point-of-care platform combining HDVI CT, fluoroscopy, and digital radiography, with a 62.5cm gantry bore and 30cm field of view. In animal health, the Vimago GT30, GT30 Pico, and Pegaso Evolution platforms serve veterinary, equine, and pre-clinical/academic research markets. In industrial robotics, the Ortis Essential/Professional/Enterprise line addresses orthotics and prosthetics milling, while SandRob and ScultoRob provide surface finishing, sanding, polishing, and 7-axis milling for aerospace, automotive, and general manufacturing. The underlying HDVI technology delivers 0.2mm spatial resolution in isotropic, non-interpolated 3D imaging.

Epica generates revenue primarily through one-time hardware sales of medical imaging platforms and robotic systems, supplemented by recurring service and support contracts delivered via its 2025 partnership with Catalyst MedTech. Distribution combines direct enterprise field sales — led by a Chief Commercial Officer and divisional presidents — with channel partnerships, notably the September 2025 Esaote North America alliance. Customer base is diversified across approximately 400 veterinary/pre-clinical imaging deployments, 170+ industrial robotic customers (including Adidas, Dallara, Weiss Automotive, Delastek, and the US VA Health Care System), and emerging human-health adopters such as Spartanburg Regional Healthcare System. The company has raised more than $50 million cumulatively across debt and equity rounds, with notable growth-capital facilities from SWK Holdings ($14M, 2018) and Avenue Capital Group ($18M, 2024), and reported FY2017 third-party-certified revenue of $24.1M.

Epica International firmographics

Firmographics
Name
Epica International
Legal name
Epica International, Inc.
Website
https://epicainternational.com
Company type
Private
Founded year
2018
Operating status
Operating
Headcount range
51–100 employees
Short description
Epica International is a privately held U.S. holding company that designs and manufactures proprietary HDVI mobile medical imaging platforms (SeeFactor CT3, Vimago) and precision robotic systems (Ortis, SandRob, ScultoRob) for human hospitals, veterinary clinics, and industrial manufacturers across the U.S. and Europe.
Ownership category
akta.pro rank

Epica International industry classification

Industry
Product category
Medical Imaging Equipment
NAICS
Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345), Irradiation Apparatus Manufacturing (334517), Surgical Appliance and Supplies Manufacturing (339113)
SIC
Surgical & Medical Instruments & Apparatus (3841), X-Ray Apparatus & Tubes & Related Irradiation Apparatus (3844), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)
akta.pro primary industry
X-ray & Fluoroscopy Systems (HLAHABAA)
akta.pro secondary industries
Teleradiology Platforms & Reading Workflow (HLACALAK), Imaging Informatics & Workflow (PACS/RIS/VNA) (HLAHABAI), Surgical Navigation, Robotics & Patient-Matched Instrumentation (Ortho/Spine) (HLAHAEAL), Universal Viewers & Enterprise Imaging Access (Zero-footprint/Diagnostic) (HLACALAD)

Keywords

  • Medical imaging systems
  • Industrial robotics
  • Orthotics prosthetics automation
  • Mobile CT imaging
  • Surface finishing robots

Where Epica International is headquartered

Location

Headquarters

HQ city
San Clemente
HQ country
United States
HQ region
North America

Offices5 records

Markets served

Epica International business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. Medical Imaging Systems: Sale of advanced mobile multi-modality imaging platforms (SeeFactor CT3 for human health, Vimago GT30/Pegaso for veterinary). One-time hardware sales with potential for recurring service contracts.
  2. Robotic Systems: Sale of industrial robotic automation systems (ORTIS, SandRob, ScultoRob) for manufacturing, aerospace, automotive, and orthotics/prosthetics industries. One-time equipment sales with software integration.
  3. Service and Support: Service and support contracts through Catalyst MedTech partnership for imaging systems. Includes maintenance, repairs, and technical support.

Pricing tiers

ModelBillingPrice
One time/ perpetual licenseMulti-year contractORTIS Essential - Entry-level O&P robotic system
One time/ perpetual licenseMulti-year contractORTIS Professional - Intermediate O&P robotic system
One time/ perpetual licenseMulti-year contractORTIS Enterprise - Maximum productivity O&P robotic system

Go-to-market motion3 records

Distribution channels3 records

Marketing channels5 records

Epica International product offering

Product offering

Core offering

Epica International designs, manufactures, and distributes advanced mobile medical imaging platforms and precision industrial robotic systems. Its human-health imaging flagship (SeeFactor CT3) and veterinary imaging platforms (Vimago GT30, GT30 Pico, Pegaso Evolution) leverage proprietary HDVI (High Definition Volumetric Imaging) technology combining CT, fluoroscopy, and digital radiography. Its robotic portfolio (Ortis line for O&P, SandRob for surface finishing, ScultoRob for milling/carving) serves orthopedic, aerospace, automotive, and general manufacturing customers.

Product overview

Epica International is a holding company for a portfolio of technology subsidiaries developing and delivering advanced medical imaging platforms and robotic systems. The company operates three main product lines: (1) Human Medical Imaging centered on the SeeFactor CT3 mobile multi-modality platform (HDVI CT, fluoroscopy, digital radiography); (2) Veterinary Medical Imaging featuring the Vimago GT30/Pico and Pegaso Evolution platforms; and (3) Industrial Robotics including the Ortis line (Essential, Professional, Enterprise) for orthotics/prosthetics manufacturing and SandRob/ScultoRob for surface finishing and carving applications. Supporting services include Peregrine PACS telemedicine reading. Products are manufactured in Italy (Florence and Pisa) with U.S. headquarters in Spartanburg, SC and business offices in San Clemente, CA.

Differentiator

Problem solved

Functional benefit

Brands

  • SeeFactor CT3: Multi-modality, mobile imaging platform utilizing HDVI technology delivering 3D map of densities with spatial resolution the same in all three dimensions; FDA 510(k) Cleared for Human Use
  • Vimago GT30
  • Vimago GT30 Pico
  • Pegaso Evolution
  • ORTIS Essential
  • ORTIS Professional
  • ORTIS Enterprise
  • ScultoRob
  • SandRob
  • Peregrine PACS

Products and services

  • SeeFactor CT3 Mobile, multi-modality point-of-care imaging platform combining HDVI CT, fluoroscopy, and digital radiography. FDA 510(k) cleared and CE marked for human use. Delivers ultra-high-definition, gapless, non-interpolated 2D/3D image data for diagnostic, interventional, and intraoperative applications in hospitals, surgical centers, and ICUs.
  • Vimago GT30

Quantifiable outcome

  • CT turnaround time in ICU reduced by more than 90%
  • +3 more outcomes

Companies that use Epica International

Customer profile

Named customers6 records

Segments4 records

Ideal customer profiles4 records

Epica International technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature6 records

Epica International partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered strategic, core and minor.

  • Esaote North AmericastrategicChannel Partner/ Reseller/ Distributor · 8 September 2025Partnership expands market presence and accelerates adoption of high-performance MR and CT across human and veterinary sectors. Esaote strengthens imaging portfolio with Epica's CT systems while Epica gains broader reach through Esaote's established North American sales and service network. Includes coordinated sales, joint marketing, and integrated support.
  • Catalyst MedTechcoreImplementation/ SI/ Consulting Partner · 21 May 2025Service partnership expands and strengthens US service infrastructure across Imaginalis and Epica Human Health to cut downtime, improve responsiveness, and deliver high-touch support. Catalyst MedTech is nationally respected leader in imaging service and support.
  • Spartanburg County / OneSpartanburgminorOthersEconomic development partnership with Spartanburg County. County supportive to business and economic development; attracted Epica as innovative company. Epica's investment aligned with diversified economic development priorities targeting bioscience and life sciences industries.

Scale indicators6 records

Recent moves10 records

Expansion highlights6 records

Epica International competitors and assessment

Company assessment

Broad incumbents

  • Carestream Health: Medical imaging and IT solutions company with X-ray, fluoroscopy and DR portfolio, including mobile imaging. Comparable as it sells multi-modality imaging systems into the same hospital and outpatient channels.
  • Philips Healthcare: Broad incumbent in diagnostic imaging, interventional and patient monitoring. Comparable as it sells directly into the same ICU/OR hospital purchasing channels that Epica targets with its mobile CT.
  • GE HealthCare: Global medical imaging incumbent with broad CT, MR and ultrasound portfolio including mobile CT solutions. Directly comparable as the dominant scale player Epica competes against in hospital imaging procurement.
  • Siemens Healthineers: Major CT, MR and interventional imaging incumbent with global hospital salesforce and service network. Comparable because it competes head-to-head with Epica's SeeFactor CT3 for hospital capital budgets.
  • Canon Medical Systems: Imaging equipment manufacturer with a strong CT portfolio, including mobile and point-of-care CT. Comparable as a peer in multi-modality diagnostic imaging capital sales to hospitals.
  • Stryker (Mako Surgical): Medical device leader with strong orthopedic and surgical robotics franchises. Comparable as it overlaps with Epica's ORTIS O&P robotic milling products and the broader surgical robotics roadmap.

Direct peers

  • Esaote: Italian-based diagnostic imaging company specializing in MR, ultrasound and—since the 2025 Epica partnership—CT. Direct comparable as both a peer in the imaging modality category and a distribution partner for Epica's CT in North America.
  • Universal Robots: Global leader in collaborative industrial robotic arms, including surface finishing, sanding and milling applications. Comparable as a direct competitor in industrial robotic automation where Roboticom's SandRob and ScultoRob operate.

Emerging players

  • Planmed: Specialty imaging OEM focused on digital mammography, CT, and orthopedic imaging. Comparable as a smaller, focused imaging manufacturer pursuing point-of-care and specialty clinical use cases similar to Epica's strategy.
  • Brainlab: Specialty surgical imaging, navigation and robotics vendor focused on image-guided surgery and intraoperative imaging. Comparable as a peer pursuing image-guided point-of-care and intraoperative imaging workflows.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Epica International social profiles

Digital presence

Epica International compliance and trust

Trust signal

Compliance2 records

Epica International financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Epica International leadership team

Management profile

Number of profiles

Profiles14 records

Epica International subsidiaries and ownership

Company hierarchy

Subsidiaries5 records

Epica International funding detail

Funding detail

Funding overview

Funding rounds14 records

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Epica International M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Epica International

What does Epica International do?

Epica International designs, manufactures, and distributes advanced mobile medical imaging platforms and precision industrial robotic systems. Its human-health imaging flagship (SeeFactor CT3) and veterinary imaging platforms (Vimago GT30, GT30 Pico, Pegaso Evolution) leverage proprietary HDVI (High Definition Volumetric Imaging) technology combining CT, fluoroscopy, and digital radiography. Its robotic portfolio (Ortis line for O&P, SandRob for surface finishing, ScultoRob for milling/carving) serves orthopedic, aerospace, automotive, and general manufacturing customers.

Is Epica International a public or private company?

Epica International is a private company. It is classified as venture growth investor backed and is currently operating.

When was Epica International founded?

Epica International was founded in 2018. It employs 51 to 100 people.

Where is Epica International based?

Epica International is headquartered in San Clemente, United States, in the North America region.

How does Epica International make money?

Three revenue lines are on record. Medical Imaging Systems are the primary driver. The others are robotic Systems and service and Support.

Who are Epica International's main competitors?

Broad incumbents on record are Carestream Health, Philips Healthcare, GE HealthCare, Siemens Healthineers, Canon Medical Systems and Stryker (Mako Surgical). Direct peers are Esaote and Universal Robots. Emerging players are Planmed and Brainlab.

Does Epica International have an API?

No public API is recorded for Epica International.

What industry is Epica International in?

Epica International's product category is Medical Imaging Equipment. Its primary akta.pro industry code is HLAHABAA, X-ray & Fluoroscopy Systems, with a secondary code of HLACALAK, Teleradiology Platforms & Reading Workflow. Its NAICS code is 3345 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PharmiWeb.comEpica International Appoints Alok K. Agrawal to Its Board of DirectorsEpica International has appointed Alok K. Agrawal, a seasoned technology and venture executive with over two decades of experience, to its Board of Directors effective October 22, 2025. Agrawal previously served as Chief Strategy Officer at Celestica and founded its strategic investment arm, Celestica Ventures, which focused on AI, robotics, and healthcare technologies. His appointment is intended to support Epica's continued global growth and innovation strategy in advanced imaging and robotics solutions for healthcare and manufacturing.NewswireEpica International Appoints Alok K. Agrawal to Its Board of DirectorsEpica International announced the appointment of Alok K. Agrawal to its Board of Directors, effective immediately. Agrawal brings over two decades of experience including his tenure as Chief Strategy Officer at Celestica, where he led global initiatives that helped double company revenue, and founded Celestica Ventures, the company's strategic investment arm focused on AI, robotics, and healthcare technologies. Agrawal currently serves as Managing Director and CEO of Agrawal Capital, LLC, a San Francisco-based firm investing in early-stage companies across artificial intelligence, robotics, automation, space, and defense sectors.PR NewswireEsaote North America and Epica International Announce Strategic Partnership to Expand MRI and CT Imaging Reach Across Human and Veterinary MarketsEsaote North America and Epica International announced a strategic partnership to expand MRI and CT imaging across human and veterinary markets. The collaboration combines Esaote's MRI and ultrasound systems with Epica's CT solutions, aiming to broaden market presence through coordinated sales and marketing.Pulse 2.0Epica International: $18 Million Growth Capital Credit Facility RaisedEpica International closed an $18 million growth capital credit facility with Avenue Venture Opportunities Funds. The initial $13.5 million will refinance debt and fund expansion, with $4.5 million in tranches tied to milestones. The lender may convert up to $3.5 million into equity at $8.50 per share.TherobotreportEpica raises $18M for industrial, medical robotsEpica International raised $18 million in growth capital from Avenue Capital Group funds. The initial $13.5 million will refinance debt and fund expansion, with $4.5 million available after milestones. The company develops medical imaging and precision robotics, including SandRob and ScultoRob systems.AbfjournalEpica Secures $18MM Growth Capital Credit Facility from Avenue CapitalEpica International closed an $18 million growth capital credit facility with Avenue Venture Opportunities Fund and Avenue Venture Opportunities Fund II, with $13.5 million funded initially and the remaining $4.5 million available in tranches upon hitting performance milestones. The four-year financing includes provisions for Avenue Capital to receive a 0.5% equity stake, an option to invest an additional $2 million in equity within two years, and the right to convert up to $3.5 million of principal into common stock at $8.50 per share. The funds will be used to refinance existing debt, support strategic expansion, and accelerate research and development initiatives in medical imaging and precision robotics.LinkedInEpica International, Inc. Secures $18 Million Growth Capital Credit Facility From Avenue Capital Group to Drive Innovation and ExpansionEpica International, Inc. has secured an $18 million growth capital credit facility from Avenue Capital Group to support innovation and expansion efforts. This funding milestone is intended to help the company broaden its reach and deliver enhanced solutions to global partners and clients.FinanzwireEpica International obtient une facilité de crédit de 18 millions de dollars pour la croissance et l'innovationEpica International Inc. secured an $18 million credit facility from Avenue Capital Group to refinance existing debt and fund strategic expansion and R&D. The four-year agreement includes a base amount of $13.5 million, with an additional $4.5 million available upon meeting specific milestones, alongside potential equity conversion options.PharmiWeb.comEpica International, Inc. Secures $18 Million Growth Capital Credit Facility From Avenue Capital Group to Drive Innovation and ExpansionEpica International Inc. has secured an $18 million growth capital credit facility from Avenue Capital Group to refinance existing debt and support strategic expansion in medical imaging and robotics. The deal includes a four-year term, with initial funding of $13.5 million and an additional $4.5 million available upon meeting performance milestones, alongside provisions for equity conversion.SecSEC FORM DEpica International, Inc. filed a Form D with the SEC on November 16, 2023, reporting an exempt securities offering under Rule 506(b) that began on August 17, 2023. The company has sold approximately $12.66 million of its total target offering amount of nearly $14 million to 200 investors, with proceeds designated for product development and general corporate purposes.